Imagine Pharmaceuticals, Inc.
San Diego
California
United States
3 articles with Imagine Pharmaceuticals, Inc.
-
Imagine Pharma Awarded Contract from National Institute of Diabetes and Digestive and Kidney Diseases's Integrated Islet Distribution Program to Provide Human Islets
8/2/2022
Imagine Pharma and Regenerative Medicine, announced today that the Integrated Islet Distribution Program (IIDP) has selected it as an approved Islet Isolation Center (IIC).
-
In a recent interview with BioSpace, Imagine Pharma CEO Ngoc Thai shared the vast potential posed by a polypeptide called IMG-1 to treat Type 1 diabetes.
-
Imagine Pharma Unveils Industry-First Generation of Insulin-Producing T1D Islet Cell Population at the American Transplant Congress
6/6/2022
Imagine Pharma, a biotechnology company focused on the development of its novel polypeptide (IMG-1) across three distinct platforms: Oral Delivery, Therapeutics, and Regenerative Medicine, will showcase its discovery of Type 1 Diabetes Activated Islet Progenitor Cells (T1D AIPCs) during its oral presentation today at the American Transplant Congress being held in Boston.